Trial Summary
What is the purpose of this trial?
This study evaluates the effects of a novel integrated clinical prediction tool on antibiotic prescription patterns of nurses for acute respiratory infections (ARIs). The intervention is an EHR-integrated risk calculator and order set to help guide appropriate, evidence-based antibiotic prescriptions for patients presenting with ARI symptoms.
Research Team
Devin Mann, MD
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for patients aged 3-70 with sore throat and 18-70 with cough, seen at participating clinics. Nurses prescribing treatment must work at least half-time, be licensed, use the clinic's EHR system regularly, and see a sufficient number of patients to maintain skills.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- iCPR system (Clinical Decision Support)
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
Dr. Alec C. Kimmelman
NYU Langone Health
Chief Executive Officer
MD and PhD from Mount Sinai School of Medicine
Dr. Nicole M. Adler
NYU Langone Health
Chief Medical Officer since 2023
MD
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
Dr. Jeanne Marrazzo
National Institute of Allergy and Infectious Diseases (NIAID)
Chief Executive Officer since 2023
MD, MPH
Dr. H. Clifford Lane
National Institute of Allergy and Infectious Diseases (NIAID)
Chief Medical Officer
MD